Pharma 4.0 Pharma digitalization and transformation- virtual event
0 likes•312 views
The document discusses the future of the pharmaceutical industry and shifting emphasis towards personalized medicine. It describes theranostics as combining diagnosis and treatment in one package, allowing time and money savings while potentially reducing undesirable biological effects. Nanomedicine uses nanoparticles in theranostics, with the goal of nanotheranostics drastically improving disease and patient-specific outcomes through a combination of targeted diagnosis and treatment.
Pharma 4.0 Pharma digitalization and transformation- virtual event
- 1. The FUTURE of PHARMA Expectation and Evolution
- 3. ❏ ❏ ❏ ❏ ❏
- 4. ❏ ❏ ❏ ❏ ❏
- 8. ❏ ❏ ❏ ❏
- 12. The future of drug discovery and development: Shifting emphasis towards personalized medicine (1) In order to achieve the ultimate goal of a more predictive and personalized medicine requires the drug discovery industry to implement more synergies between the two worlds of clinical research and diagnostics. The therapeutics that are enabled by that strategy are often called “THERANOSTICS”
- 13. ● ● ● ● The future of drug discovery and development: Shifting emphasis towards personalized medicine
- 15. THERANOSTICS is The ability to acquire a diagnosis and administer therapy in one package is a game-changer for medicine as we know it. Not only does this offer the opportunity to save time and money, but it also potentially allows one to bypass some of the undesirable biological effects that may arise when these strategies are employed separately. NANOMEDICINE is the use of nanoparticles in theranostics. The ultimate aim of combining nanomedicine and theranostics is to modify disease and patient-specific outcomes in such a way that they are drastically improved. NANOTHERANOSTICS is a combination of aforementioned elements.